Aligos Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.

About ALGS

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in in developing therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). 

CEO
Lawrence M. Blatt
CEOLawrence M. Blatt
Employees
93
Employees93
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
93
Employees93

ALGS Key Statistics

Market cap
38.52M
Market cap38.52M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
82.51K
Average volume82.51K
High today
$1.12
High today$1.12
Low today
$0.91
Low today$0.91
Open price
$1.03
Open price$1.03
Volume
40.16K
Volume40.16K
52 Week high
$16.50
52 Week high$16.50
52 Week low
$0.86
52 Week low$0.86

ALGS Earnings

-$0.90
-$0.60
-$0.30
-$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 9, After Hours
ActualExpected Mar 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.